Here, we report a study of JAK2 (V617F) mutation in 75 normal subjects referred to the Outpatient Section of the Department of Haematology of Pavia. These healthy individuals (aged from 18 to 79 years) displayed a normal blood cell count without spleen enlargement. Applying AS-PCR as previously described (Passamonti et al, 2006), we did not find the mutation in any case.

JAK2 (V617F) mutation in healthy individuals

PASSAMONTI, FRANCESCO;
2007-01-01

Abstract

Here, we report a study of JAK2 (V617F) mutation in 75 normal subjects referred to the Outpatient Section of the Department of Haematology of Pavia. These healthy individuals (aged from 18 to 79 years) displayed a normal blood cell count without spleen enlargement. Applying AS-PCR as previously described (Passamonti et al, 2006), we did not find the mutation in any case.
2007
JAK2; Myeloproliferative neoplasm
Passamonti, Francesco; Rumi, E; Pietra, D; Lazzarino, M; Cazzola, M.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2023261
 Attenzione

L'Ateneo sottopone a validazione solo i file PDF allegati

Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 28
social impact